A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging

2.7K views

DOI:

10.3791/64875

March 17th, 2023

* These authors contributed equally

In This Article

Summary

The present protocol describes a detailed, real-time NIR-II fluorescence imaging operation of a mouse using a NIR-II optics imaging device.

Abstract

As an emerging imaging technology, near-infrared II (NIR-II, 1000-1700 nm) fluorescence imaging has significant potential in the biomedical field, owing to its high sensitivity, deep tissue penetration, and superior imaging with spatial and temporal resolution. However, the method to facilitate the implementation of NIR-II fluorescence imaging for some urgently needed fields, such as medical science and pharmacy, has puzzled relevant researchers. This protocol describes in detail the construction and bioimaging applications of a NIR-II fluorescence molecular probe, HLY1, with a D-A-D (donor-acceptor-donor) skeleton. HLY1 showed good optical properties and biocompatibility. Furthermore, NIR-II vascular and tumor imaging in mice was performed using a NIR-II optics imaging device. Real-time high-resolution NIR-II fluorescence images were acquired to guide the detection of tumors and vascular diseases. From probe preparation to data acquisition, the imaging quality is greatly improved, and the authenticity of the NIR-II molecular probes for data recording in intravital imaging is ensured.

Introduction

Fluorescence imaging is the commonly used molecular imaging tool in basic research, and is also often used to guide surgical tumor resection in clinics1. The essential principle of fluorescence imaging is to employ a camera to receive fluorescence emitted by a laser after the irradiation of samples (tissues, organs, etc.)2. The process is completed within a few milliseconds3. The fluorescence imaging wavelengths can be divided into ultraviolet (200-400 nm), visible region (400-700 nm), near-infrared I (NIR-I, 700-900 nm), and near-infrared II (NIR-II, 1000-1700 nm)4,

Access restricted. Please log in or start a trial to view this content.

Protocol

Animal experiments for NIR-II imaging studies were conducted at the Animal Experiment Center of Wuhan University, which has been awarded the International Association for Experimental Animal Care (AALAC). All animal studies were conducted following the China Animal Welfare Commission Guidelines for the Care and Use of Experimental Animals and approved by the Animal Care and Use Committee (IACUC) of the Animal Experimental Center of Wuhan University.

Female BALB/c nude mice (~20 g) at 6 weeks of age were used for the present study.

1. NIR-II imaging preparation

  1. Place commercially avail....

Access restricted. Please log in or start a trial to view this content.

Results

The fluorescent intensity and brightness of water-suspensible HLY1 dots were determined by an NIR-II imaging instrument. The fluorescent intensity of HLY1 in the 90% fwTHF/H2O mixture was five times that in the THF solution, which indicated a prominent AIE feature of HLY1 (Figure 1B). Moreover, HLY1 dots emitted strong fluorescent signals under a 1,500 nm LP filter, showing that HLY1 dots can be used for NIR-IIb imaging (Figure 1D).......

Access restricted. Please log in or start a trial to view this content.

Discussion

NIR-I fluorescent imaging can be used to some extent for tumor and vascular imaging, but due to the limited maximum emission wavelength of NIR-I fluorophores (<900 nm), it results in poor tissue penetration and tumor signal background ratio33,34. Poor and low imaging resolution may cause a deviation between the outcome of the imaging feedback treatment and the actual therapeutic effect. In addition, most NIR-I fluorophores have poor optical stability and extr.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was partially supported by grants from NSFC (82273796, 82111530209), Special Funds for Guiding Local Science and Technology Development of Central Government (XZ202202YD0021C, XZ202102YD0033C, XZ202001YD0028C), Hubei Province Scientific and Technical Innovation Key Project (2020BAB058), the Fundamental Research Funds for the Central Universities, and the Tibet Autonomous Region COVID-19 Prevention and Control Programs for Science and Technology Development.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Anhydrous pyridinePerimed 110-86-1
Anhydrous sodium sulfateChina national medicines Co.,LtdSY006376
Black cardboardSuzhou Yingrui Optical Technology Co., LtdAO00158
Column chromatographyEnergy ChemicalE080498
Diphenylphosphine palladium dichlorideSigma-AldrichB2161-1g
DSPE-PEG2000PonsurePS-E1
Dulbecco's modified eagle medium Gibco8121587
EGTABiofroxxEZ6789D115
Fetal bovine serumGibco2166090RP
IsofluraneGLPBIOGC45487-1
K2CO3MacklinP816305-5g
N. N '- dimethylformamideChina national medicines Co.,Ltd02-12-1968
NIR-II imaging instrumentSuzhou Yingrui Optical Technology Co., Ltd16011109
N-sulfenanilideEnerry chemical 1250030-5g
PdCl2(dppf)2CH2Cl2TCI B2064-1g
penicillin-streptomycinGibco15140-122
TetrahydrofuranChina national medicines Co.,LtdM005197
Tetratriphenylphosphine palladiumImmochem1021232-5g
Tetratriphenylphosphine palladiumSigma-Aldrich1021232-5g
Tributyltin chlorideImmochemQH004335
TrimethylchlorosilaneChina national medicines Co.,Ltd40060560

References

  1. Liu, Y., et al. Versatile types of inorganic/organic NIR-IIa/IIb fluorophores: from strategic design toward molecular imaging and theranostics. Chemical Reviews. 122 (1), 209-268 (2022).
  2. Zhou, H., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Vascular ImagingIn Vivo ImagingHLY1 DotsNanoprecipitation MethodOptical Imaging SystemAggregation Induced EmissionDynamic Light Scattering